期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 14, 期 10, 页码 20597-20613出版社
MDPI
DOI: 10.3390/ijms141020597
关键词
EGFR; EGF-like ligands; vascular disease; atherosclerosis; cardiac remodeling
资金
- Office of Research and Development, Department of Veterans Affairs [1BX001729]
- American Heart Association [GRNT12060205]
The epidermal growth factor receptor (EGFR) family and its ligands serve as a switchboard for the regulation of multiple cellular processes. While it is clear that EGFR activity is essential for normal cardiac development, its function in the vasculature and its role in cardiovascular disease are only beginning to be elucidated. In the blood vessel, endothelial cells and smooth muscle cells are both a source and a target of EGF-like ligands. Activation of EGFR has been implicated in blood pressure regulation, endothelial dysfunction, neointimal hyperplasia, atherogenesis, and cardiac remodeling. Furthermore, increased circulating EGF-like ligands may mediate accelerated vascular disease associated with chronic inflammation. Although EGFR inhibitors are currently being used clinically for the treatment of cancer, additional studies are necessary to determine whether abrogation of EGFR signaling is a potential strategy for the treatment of cardiovascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据